Compound Library

In-depth compound profiles

Citations-first pages — mechanism, pharmacokinetics, the real evidence tier, and regulatory status for each compound. New profiles added regularly.

Research framed. Educational only — not medical advice, not dosing. Each page states whether a compound is FDA-approved, investigational, or research-use-only.

RUO · not approved

5-Amino-1MQ

Metabolic research

Evidence: preclinical

RUO · not approved

5-Amino-1MQ (Oral)

Metabolic research

Evidence: preclinical

RUO · not approved

Adipotide

Metabolic research

Evidence: preclinical

Topical cosmetic · injectable RUO

AHK-Cu

Skin & cosmetic

Evidence: cosmetic/preclinical

RUO · not approved

AOD-9604

Metabolic research

Evidence: preclinical / early

Investigational

ARA-290

Healing & repair

Evidence: early clinical

RUO · not approved

BAM-15

Metabolic research

Evidence: preclinical

RUO · not FDA-approved · WADA-prohibited

BPC-157

Healing & tissue-repair research

Evidence: preclinical + early pilots

RUO · WADA-prohibited

BPC-157 (Oral)

Healing & repair

Evidence: preclinical

RUO · WADA-prohibited

BPC-157 + TB-500 (Oral 500/500 mcg)

Peptide blend

Evidence: preclinical (components)

RUO · not approved

Bronchogen

Peptide bioregulator

Evidence: Russian preclinical

Investigational

Cagrilintide

Metabolic research

Evidence: Phase 2/3 (as combo)

Investigational (combo)

CagriSema (Cagrilintide + Semaglutide)

Peptide blend

Evidence: Phase 3

RUO · not approved

Cardiogen

Peptide bioregulator

Evidence: Russian preclinical

RUO · not approved

Cartalax

Peptide bioregulator

Evidence: Russian preclinical

Approved in some countries · not US

Cerebrolysin

Cognitive research

Evidence: clinical (mixed)

RUO · WADA-prohibited

CJC-1295 (No DAC)

GH secretagogue

Evidence: preclinical / early

RUO · not FDA-approved · WADA-prohibited

CJC-1295 + Ipamorelin

Growth-hormone secretagogues

Evidence: early human PK / preclinical

RUO · not approved

Crystagen

Peptide bioregulator

Evidence: Russian preclinical

RUO / investigational (components)

Dihexa + Methylene Blue + Tesofensine (Oral)

Peptide blend

Evidence: preclinical (components)

RUO · not approved

DSIP

Sleep research

Evidence: preclinical / inconsistent

RUO · not approved

Epitalon

Longevity & cellular

Evidence: mostly Russian preclinical/clinical

Topical: cosmetic use · Injectable: RUO

GHK-Cu

Cosmetic · skin & tissue-repair

Evidence: cosmetic/preclinical

RUO · WADA-prohibited

GHRP-2

GH secretagogue

Evidence: early human PK

RUO · WADA-prohibited

GHRP-6

GH secretagogue

Evidence: early human PK

RUO · WADA considerations

Glow blend (BPC-157 / GHK-Cu / TB-500)

Peptide blend

Evidence: preclinical (components)

FDA-approved (specific indications)

hCG

Hormonal research

Evidence: FDA-approved (specific uses)

RUO · WADA considerations

Hulk blend

Peptide blend

Evidence: preclinical (components)

RUO · WADA-prohibited

IGF1-LR3

Growth & cellular

Evidence: preclinical

RUO · WADA-prohibited

Ipamorelin

GH secretagogue

Evidence: preclinical / early

Investigational

Kisspeptin

Hormonal research

Evidence: early clinical

RUO · WADA considerations

Klow blend (GHK-Cu / KPV / BPC-157 / TB-500)

Peptide blend

Evidence: preclinical (components)

RUO · not approved

KPV

Immune / healing

Evidence: preclinical

RUO · not approved

KPV (Oral 500 mcg)

Immune / healing

Evidence: preclinical

Supplement / approved (deficiency)

L-Carnitine

Metabolic research

Evidence: mixed human

Supplement / RUO (injectable)

L-Glutathione

Antioxidant research

Evidence: mixed human

Not approved · RUO/cosmetic

Lemon Bottle

Cosmetic research

Evidence: none peer-reviewed

Compounded · not FDA-approved

Lipo Shredder

Peptide blend

Evidence: weak/none

Compounded · not FDA-approved as a combo

Lipo-B

Peptide blend

Evidence: weak/none

Compounded · not FDA-approved as a combo

Lipo-C

Peptide blend

Evidence: weak/none

Compounded · not FDA-approved as a combo

Lipo-Mino Mix

Peptide blend

Evidence: weak/none

RUO · not approved

LL-37

Immune / healing

Evidence: preclinical

Investigational

Mazdutide

Metabolic research

Evidence: Phase 3 (ongoing)

RUO · not approved

Melanotan II

Skin & cosmetic

Evidence: preclinical / anecdotal

FDA-approved (specific indication)

Methylene Blue (Oral 25 mg)

Mitochondrial research

Evidence: approved (specific) + emerging

RUO · WADA-prohibited

MK-677 (Oral 25 mg)

GH secretagogue

Evidence: human trials (not approved)

RUO · not FDA-approved

MOTS-c

Metabolic · mitochondrial

Evidence: preclinical (early human interest)

Not a peptide · not an approved drug

NAD+

Longevity · cellular coenzyme

Evidence: preclinical / emerging human

Investigational

Orforglipron

Metabolic research

Evidence: Phase 3 (ongoing)

FDA-approved (specific uses)

Oxytocin

Hormonal research

Evidence: FDA-approved (obstetric)

RUO · not approved

Pancragen

Peptide bioregulator

Evidence: Russian preclinical

RUO · not approved

Pinealon

Peptide bioregulator

Evidence: Russian preclinical

RUO · not approved

Prostamax

Peptide bioregulator

Evidence: Russian preclinical

FDA-approved (specific indication)

PT-141

Melanocortin · sexual-health research

Evidence: Phase 3 (approved indication)

Investigational · not approved

Retatrutide

Metabolic · triple incretin

Evidence: Phase 2 (Phase 3 ongoing)

Approved in Russia · RUO elsewhere

Selank

Cognitive research

Evidence: mostly Russian clinical

FDA-approved drug

Semaglutide

Metabolic · incretin (GLP-1)

Evidence: large Phase 3 RCTs

Approved in Russia · RUO elsewhere

Semax

Cognitive research

Evidence: mostly Russian clinical

Approval withdrawn · now RUO/compounded

Sermorelin Acetate

GH secretagogue

Evidence: was FDA-approved (diagnostic)

RUO · not approved

SLU-PP-332

Metabolic research

Evidence: preclinical

RUO · not approved

SLU-PP-332 + 5-Amino-1MQ (Oral)

Peptide blend

Evidence: preclinical (components)

RUO · not approved

SLU-PP-332 + BAM-15

Peptide blend

Evidence: preclinical (components)

RUO + investigational (components)

SLU-PP-332 + Orforglipron

Peptide blend

Evidence: mixed (components)

Topical cosmetic

Snap-8

Skin & cosmetic

Evidence: cosmetic/topical

Investigational

SS-31

Longevity & cellular

Evidence: clinical (mixed)

Investigational

Survodutide

Metabolic research

Evidence: Phase 2/3

RUO · not FDA-approved · WADA-prohibited

TB-500

Healing & tissue-repair research

Evidence: preclinical (minimal human)

FDA-approved (specific indication)

Tesamorelin

GH secretagogue (GHRH analog)

Evidence: Phase 3 (approved indication)

Investigational

Tesofensine

Metabolic research

Evidence: Phase 2 (Phase 3 pending)

Approved in some countries · RUO in US

Thymosin Alpha-1

Immune / healing

Evidence: approved in some regions

FDA-approved drug

Tirzepatide

Metabolic · dual incretin

Evidence: large Phase 3 RCTs

RUO · not approved

Vilon

Peptide bioregulator

Evidence: Russian preclinical

RUO (research); niche approved uses

VIP (Vasoactive Intestinal Peptide)

Immune / healing

Evidence: preclinical / niche clinical

Supplement / approved (deficiency)

Vitamin B12

Vitamin support

Evidence: established (deficiency)

RUO · WADA-prohibited

Wolverine Blend (BPC-157 + TB-500)

Peptide blend

Evidence: preclinical (components)